72.11.Z - Scientific research and development activities
20 - Manufacture of chemicals and chemical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
22 - Manufacture of rubber and plastic products
28 - Manufacture of machines and equipment not elsewhere classified
46 - Wholesale trade
47 - Retail trade
62 - Activities related to programming, IT consulting, and related activities
74 - Other professional, scientific and technical activities
86 - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -0,6 | -57,5 | 20,6 | 135,7 |
EBITDA | -0,8 | -109 | ||
Short time liabilities | 10,5 | 320,2 | ||
Income tax | 0 | 0 | 0 | |
Equity capital | 10,5 | -47 | -26,5 | 43,7 |
Operating profit (EBIT) | -0,8 | -109 | ||
Assets | 21,2 | 41,1 | 23,8 | -42,2 |
Net profit (loss) | -0,8 | -57,5 | 20,6 | 135,7 |
Cash | 3,6 | -24,9 | ||
Net income from sale | 185,6 | 381,7 | ||
Liabilities and provisions for liabilities | 10,7 | 88,1 | 50,2 | -43 |
Working assets | 21,2 | 30,5 | 15,5 | -49 |
Basic operational activity income | 306,2 | 230,2 | -24,8 | |
Depreciation | 0 | 0 | ||
% | % | % | p.p. | |
Profitability of capital | -8 | -80,1 | ||
Equity capital to total assets | 49,6 | -114,3 | -111,3 | 3 |
Gross profit margin | -0,3 | -18,8 | 8,9 | 27,7 |
EBITDA Margin | -0,4 | -24,2 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 21 | -3 | ||
Current financial liquidity indicator | 2.0181171894073486 | -10,4 | ||
Net dept to EBITDA | 4.131163597106934 | 2,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane